Home Peritoneal pseudomyxoma after incomplete appendectomy
Article Open Access

Peritoneal pseudomyxoma after incomplete appendectomy

  • Dahbia Djelil , Anthony Dohan and Marc Pocard EMAIL logo
Published/Copyright: August 20, 2020

A 41-year-old woman was referred because of abdominal pain, reporting on an appendectomy 24 years ago. At that time, she developed a postoperative intra-abdominal abscess and was told that the tip of the appendix had been left in the abdomen. Seventeen years later, a CT-scan showed a 6 cm cystic tumor at the caecum base (Figure 1A). The treatment was conservative. The abdominal CT-scan now showed a 15 cm large tumor (Figure 1B). A low-grade pseudomyxoma peritonei (PMP) with a Peritoneal Cancer Index (PCI) of 6/39 was diagnosed.

Figure 1: (A, B) Evolution of remnant tips of appendix generating a mucocele after 17 years and a pseudomyxoma peritonei (PMP) of low grade after 24 years. (C) Evolution of remnant tips of appendix generating a pseudomyxoma peritonei (PMP) of low grade. Per operative aspect with white arrow, on the last small bowel loop, of a remnant tips of appendix origin of the PMP.
Figure 1:

(A, B) Evolution of remnant tips of appendix generating a mucocele after 17 years and a pseudomyxoma peritonei (PMP) of low grade after 24 years. (C) Evolution of remnant tips of appendix generating a pseudomyxoma peritonei (PMP) of low grade. Per operative aspect with white arrow, on the last small bowel loop, of a remnant tips of appendix origin of the PMP.

A 59-year-old man presented with abdominal pain nine years after a laparoscopic appendectomy. He reported on an intra-abdominal abscess eight months postoperatively, requiring radiological drainage. A low-grade PMP (PCI 12) was diagnosed, and an appendix tip remnant identified (Figure 1C).

A PMP can arise from an appendiceal tip remnant. A history of appendectomy does not exclude an appendiceal origin of PMP.


Corresponding author: Marc Pocard, Department of Digestive and Oncologic surgery, Hôpital Lariboisière-AP-HP, Université Paris Diderot-Paris 7, Paris, France; and Université de paris, CAP-PAris Tech, INSERM U1275, Lariboisière Hospital, Paris, France, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: Informed consent given by the patient (Registration in RENAPE network, organization for the treatment of rare tumors of the peritoneum), CNIL 2010-297.

Received: 2020-05-03
Accepted: 2020-05-27
Published Online: 2020-08-20

© 2020 Dahbia Djelil et al., published by de Gruyter GmbH, Berlin/Boston.

This work is licensed under the Creative Commons Attribution 4.0 International License.

Downloaded on 24.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/pp-2020-0119/html
Scroll to top button